Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Subcommittee retains bill on insurance coverage for continuous glucose monitors; fiscal and eligibility questions remain
Summary
Members retained House Bill 648, which would expand insurer coverage of continuous glucose monitoring (CGM) devices. Lawmakers and the Insurance Department debated eligibility criteria, fiscal estimates, and clinical thresholds for coverage; committee voted to retain while staff and the department develop narrower language and cost estimates.
The House Commerce and Consumer Affairs subcommittee voted to retain House Bill 648, which would change insurance coverage rules for continuous glucose monitoring (CGM) devices used by people with diabetes.
Supporters argued CGMs can prevent complications and improve diabetes management; several members cautioned coverage criteria should be narrowly drawn to avoid large premium impacts. Representative Spear said a fiscal estimate he circulated suggested an added cost of about $22 per year per family member under the unamended bill, but department staff later…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
